The cost-effectiveness of risedronate in the treatment of osteoporosis: an international perspective

被引：0
|
作者：
F. Borgström
Å. Carlsson
H. Sintonen
S. Boonen
P. Haentjens
R. Burge
O. Johnell
B. Jönsson
J. A. Kanis
机构：
[1] Stockholm Health Economics,Medical Management Centre
[2] Karolinska Institutet,Department of Public Health
[3] University of Helsinki,Leuven University Center for Metabolic Bone Diseases and Division of Geriatric Medicine
[4] Katholieke Universiteit Leuven,Department of Orthopaedics and Traumatology
[5] Academisch Ziekenhuis van de Vrije Universiteit Brussel,Division of Pharmaceutical Sciences, College of Pharmacy
[6] Procter & Gamble Pharmaceuticals,Department of Orthopaedics
[7] University of Cincinnati,Department of Economics
[8] Malmö General Hospital,Centre for Metabolic Bone Diseases (WHO Collaborating Centre)
[9] Stockholm School of Economics,undefined
[10] University of Sheffield Medical School,undefined
来源：
Osteoporosis International | 2006年 / 17卷
关键词：
Belgium; Cost-effectiveness; Finland; Fracture; Osteoporosis; Postmenopausal women; Risedronate; Spain; Sweden;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：996 / 1007
页数：11
相关论文
共 50 条
  • [1] The cost-effectiveness of risedronate in the treatment of osteoporosis:: an international perspective
    Borgstrom, F.
    Carlsson, A.
    Sintonen, H.
    Boonen, S.
    Haentjens, P.
    Burge, R.
    Johnell, O.
    Jonsson, B.
    Kanis, J. A.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2006, 17 (07) : 996 - 1007
  • [2] The cost-effectiveness of risedronate treatment in Japanese women with osteoporosis
    Hansheng Ding
    Nobuo Koinuma
    Matt Stevenson
    Michiya Ito
    Yasutake Monma
    [J]. Journal of Bone and Mineral Metabolism, 2008, 26 : 34 - 41
  • [3] The cost-effectiveness of risedronate treatment in Japanese women with osteoporosis
    Ding, Hansheng
    Koinuma, Nobuo
    Stevenson, Matt
    Ito, Michiya
    Monma, Yasutake
    [J]. JOURNAL OF BONE AND MINERAL METABOLISM, 2008, 26 (01) : 34 - 41
  • [4] Cost-effectiveness of risedronate for the treatment of osteoporosis and prevention of fractures in postmenopausal women
    J. A. Kanis
    F. Borgstrom
    O. Johnell
    B. Jonsson
    [J]. Osteoporosis International, 2004, 15 : 862 - 871
  • [5] Cost-effectiveness of risedronate for the treatment of osteoporosis and prevention of fractures in postmenopausal women
    Kanis, JA
    Borgstrom, F
    Johnell, O
    Jonsson, B
    [J]. OSTEOPOROSIS INTERNATIONAL, 2004, 15 (11) : 862 - 871
  • [6] The cost-effectiveness of risedronate in the UK for the management of osteoporosis using the FRAXA®
    Borgstrom, F.
    Strom, O.
    Coelho, J.
    Johansson, H.
    Oden, A.
    McCloskey, E. V.
    Kanis, J. A.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2010, 21 (03) : 495 - 505
  • [7] COST-EFFECTIVENESS OF RISEDRONATE FOR CORTICOSTEROID-INDUCED OSTEOPOROSIS IN AUSTRALIA
    Liew, D.
    Gonzalo, F.
    Lewis, T.
    [J]. VALUE IN HEALTH, 2010, 13 (07) : A558 - A559
  • [8] The cost-effectiveness of risedronate in the UK for the management of osteoporosis using the FRAX®
    F. Borgström
    O. Ström
    J. Coelho
    H. Johansson
    A. Oden
    E. V. McCloskey
    J. A. Kanis
    [J]. Osteoporosis International, 2010, 21 : 495 - 505
  • [9] Cost-effectiveness of gastro-resistant risedronate tablets for the treatment of postmenopausal women with osteoporosis in France
    Hiligsmann, M.
    Reginster, J. -Y.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2019, 30 (03) : 649 - 658
  • [10] Cost-effectiveness of gastro-resistant risedronate tablets for the treatment of postmenopausal women with osteoporosis in France
    M. Hiligsmann
    J.-Y. Reginster
    [J]. Osteoporosis International, 2019, 30 : 649 - 658
12345